Tech Company Financing Transactions

Peptimmune Funding Round

Covera Ventures, Itochu Corporation and MPM Capital joined a $20.4 million Series C funding round for Peptimmune. The funding round was announced on 7/15/2005.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

64 Sidney Street 380
Cambridge, MA 02139
USA

Phone

(617) 715-8000

Website

www.peptimmune.com

Email Address

[email protected]

Overview

Peptimmune is a clinical stage biotechnology company that is utilizing both novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Fredric Price

        

Chief Executive Officer

Thomas Mathers

        

VP - R & D

Eric Zanelli

        

VP - Regulatory Affairs

Uday Patel

        

Browse more venture capital transactions:

Prev: 7/14/2005: Immune Control venture capital transaction
Next: 7/15/2005: Qmobile venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary